Ethical Responsibility of Digital Pills Technology - Take Abilify Mycite For Example

Ming Luo ； Shuangsheng Yan

《International Journal of Social Science and Education Research》 2卷6期 (2019/09) Pp. 96-98

https://doi.org/10.6918/IJOSSER.201909_2(6).0015

摘要

Digital pills are new medicine combining digital technology with traditional medicine. Therefore, investigation of digital pills is an emerging field of drug research and development. Abilify MyCite, as the first digital pill around world, was approved by FDA in November, 2017. The original intention of digital pills technology is to continuously monitor patients' diseases at a distance and improve medication compliance of patients, so that the treatment effect could be increased. The development of digital technology and the advent of digital medicine created ethical challenges to patients, health care workers and medical practice. Taking Abilify MyCite as an example, this paper studied the digital medicine which may bring ethical problems, and put forward the idea that integrating responsible innovation into the research and development of digital medicine as well as solving the ethical problems in aspects of technology, law, management and ethics is an effective way to solve the ethical dilemma.

關鍵字

Digital pills ； medical ethics ； ethical responsibility

參考文獻

Phan, S. V. 2016. Medication adherence in patients with schizophrenia. The International Journal of Psychiatry in Medicine 51 (2): 211–9.

Klugman, C. M., L. B. Dunn, J. Schwartz, and I. G. Cohen. 2018. The ethics of smart pills and self-acting devices: Autonomy, truth-telling, and trust at the dawn of digital medicine. American Journal of Bioethics 18(9): 38–47.

Anonymous. FDA approved the world's first digital drug to track whether a patient is taking the drug [J]. China Digital Medicine, 2017 (11): 47-47.

Li Zhenliang. Development of Digital Medicine and Ethics.[J], Medicine and Philosophy [A]2018, 39 (3): 24-27.